Patents by Inventor Michael Hensley

Michael Hensley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapies of cicletanine and magnesium
    Publication number: 20060153934
    Abstract: Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and magnesium for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome.
    Type: Application
    Filed: January 13, 2005
    Publication date: July 13, 2006
    Inventors: Glenn Cornett, Michael Hensley, Lance Fors
  • Combination therapies of cicletanine and carvedilol
    Publication number: 20060154959
    Abstract: Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and carvedilol for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome.
    Type: Application
    Filed: January 13, 2005
    Publication date: July 13, 2006
    Inventors: Glenn Cornett, Michael Hensley, Lance Fors
  • Combination therapies of cicletanine and lacidipine
    Publication number: 20060154971
    Abstract: Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and lacidipine (a preferred calcium antagonist) for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome.
    Type: Application
    Filed: January 13, 2005
    Publication date: July 13, 2006
    Inventors: Glenn Cornett, Michael Hensley, Lance Fors